FDA Inspection 1049424 — Maxill Inc.
The FDA completed an inspection of Maxill Inc. on Apr 18, 2018 in Cortland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 18, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cortland, OH (United States)